The promoter group holds 57.68 percent stake while the bloc of private equity investors holds 31.52 percent in SRL Diagnostics. The investors include the likes of NY Jacob Ballas and the World Bank#39;s development finance arm IFC
The promoter group holds 57.68 percent stake while the bloc of private equity investors holds 31.52 percent in SRL Diagnostics. The investors include the likes of NY Jacob Ballas and the World Bank#39;s development finance arm IFC The promoter group holds 57.68 percent stake while the bloc of private equity investors holds 31.52 percent in SRL Diagnostics. The investors include the likes of NY Jacob Ballas and the World Bank#39;s development finance arm IFC Moneycontrol Latest News Read More
English 
हिन्दी